https://clinicaltrials.gov/ct2/show/NCT04128007?type=Intr&cond=Psoriasis&lupd_s=10%2F02%2F2019&lupd_d=14
Condition : Plaque Psoriasis
Intervention : Drug: ARQ-154
Sponsor : Arcutis, Inc.
Not yet recruiting
Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
NCT04128007
Wed, 16 Oct 2019 12:00:00 EDT
Last Update Posted: 10/16/19 08:20AM
